Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 283.00K | 3.00M | 4.92M | 7.66M | 7.03M |
| Total Depreciation and Amortization | 1.93M | 292.00K | 289.00K | 273.00K | 269.00K |
| Total Amortization of Deferred Charges | 22.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.00K | 110.00K | -1.08M | 767.00K | -3.27M |
| Change in Net Operating Assets | -248.00K | 2.83M | -1.70M | -6.28M | 1.95M |
| Cash from Operations | 2.00M | 6.23M | 2.43M | 2.42M | 5.97M |
| Capital Expenditure | -80.02M | -11.00K | -6.00K | -21.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -123.00K | -- |
| Cash from Investing | -80.02M | -11.00K | -6.00K | -144.00K | -- |
| Total Debt Issued | 40.00M | -- | -- | -- | -- |
| Total Debt Repaid | -106.00K | -29.00K | -28.00K | -36.00K | -29.00K |
| Issuance of Common Stock | 10.00K | 24.00K | 103.00K | 196.00K | 134.00K |
| Repurchase of Common Stock | 0.00 | 0.00 | -176.00K | -5.10M | -132.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -398.00K | -- | -- | -- | -- |
| Cash from Financing | 39.51M | -5.00K | -101.00K | -4.94M | -27.00K |
| Foreign Exchange rate Adjustments | 52.00K | -206.00K | -171.00K | 408.00K | -196.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.46M | 6.00M | 2.16M | -2.26M | 5.75M |
